Multi-Cancer Screening vs Single-Cancer Tests: What’s the Difference?

Single-cancer screening tests are designed to look for signs of one specific type of cancer at a time. This is the traditional approach to cancer screening and is supported by decades of research and established screening guidelines. With this type of testing, each screening is tailored to a particular cancer, such as breast, cervical, or colorectal cancer, using methods developed for that specific purpose.[1,2,3]

The fact that single-cancer screening tests are cancer-specific is a major advantage. This focused design often comes with clearer screening recommendations and more established next steps if a result is abnormal. However, the same focus is also its limitation. A single-cancer screening test is not designed to provide information about other cancers, so you don’t gain broader insight beyond the specific cancer the test is meant to screen for.

Multi-cancer screening, often called multi-cancer early detection (MCED) screening, refers to tests designed to look for signs associated with multiple types of cancer at the same time using a single sample. Most MCED tests analyze blood, and in some cases other body fluids, for biological signals such as fragments of DNA, RNA, or proteins that may be released by abnormal cells.[4]

One potential advantage of multi-cancer screening is its broader scope. Instead of focusing on one specific cancer, these tests aim to detect signals that could be linked to many cancers, including some that currently have no routine screening options. Some MCED tests may also suggest where a cancer signal originated, while others only indicate that a cancer-associated signal may be present.

However, multi-cancer screening has important limitations. MCED tests do not diagnose cancer, are not yet FDA-approved, and positive results require additional testing to determine whether cancer is present, what type it may be, and where it is located. Negative results also do not rule cancer out.

There is no single cancer screening test that works for everyone. Single-cancer screening tests and multi-cancer screening serve different purposes, and the right approach depends on individual factors such as age, personal and family history, overall health, and access to follow-up care.

Established single-cancer screenings remain an important part of preventive care and are recommended for many people based on clear guidelines. Multi-cancer screening, on the other hand, may be considered by some individuals as an additional option, particularly because it aims to detect signals linked to cancers that do not yet have routine screening tests.

However, these tests come with uncertainties, including the possibility of false-positive or false-negative results and the need for further testing if a signal is detected. For these reasons, decisions about cancer screening are best made through informed discussions with a healthcare provider, taking personal values and preferences into account.

Single-cancer screening tests and multi-cancer screening are designed to answer different questions. Single-cancer tests focus on one specific cancer and follow long-established screening recommendations. Multi-cancer early detection (MCED) tests aim to detect cancer-associated signals across multiple cancers using a single sample, but they do not diagnose cancer and do not replace recommended screenings.

If you are exploring screening options, Everlywell offers access to at-home health testing and select screening options, including the Galleri® multi-cancer early detection test. Understanding what each approach can and cannot tell you can help you discuss next steps with a healthcare provider.

References

1. Professional CCM. Mammogram. Cleveland Clinic. Published January 23, 2026. Accessed February 3, 2025. https://my.clevelandclinic.org/health/diagnostics/4877-mammogram.
2. Cervical cancer screening. Cancer.gov. Published February 13, 2025. Accessed February 3, 2025. https://www.cancer.gov/types/cervical/screening.
3. Screening for colorectal cancer. Colorectal Cancer. Published February 26, 2025. Accessed February 3, 2025. https://www.cdc.gov/colorectal-cancer/screening/index.html.
4. Multi-cancer detection (MCD) tests. American Cancer Society. Accessed February 3, 2025. https://www.cancer.org/cancer/screening/multi-cancer-early-detection-tests.html.